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Dialysis adequacy predictions using 
a machine learning method
Hyung Woo Kim1,5, Seok‑Jae Heo2,5, Jae Young Kim1,3, Annie Kim2, Chung‑Mo Nam2,4* & 
Beom Seok Kim1*
Dialysis adequacy is an important survival indicator in patients with chronic hemodialysis. However, 
there are inconveniences and disadvantages to measuring dialysis adequacy by blood samples. This 
study used machine learning models to predict dialysis adequacy in chronic hemodialysis patients 
using repeatedly measured data during hemodialysis. This study included 1333 hemodialysis sessions 
corresponding to the monthly examination dates of 61 patients. Patient demographics and clinical 
parameters were continuously measured from the hemodialysis machine; 240 measurements were 
collected from each hemodialysis session. Machine learning models (random forest and extreme 
gradient boosting [XGBoost]) and deep learning models (convolutional neural network and gated 
recurrent unit) were compared with multivariable linear regression models. The mean absolute 
percentage error (MAPE), root mean square error (RMSE), and Spearman’s rank correlation coefficient 
(Corr) for each model using fivefold cross‑validation were calculated as performance measurements. 
The XGBoost model had the best performance among all methods (MAPE = 2.500; RMSE = 2.906; 
Corr = 0.873). The deep learning models with convolutional neural network (MAPE = 2.835; 
RMSE = 3.125; Corr = 0.833) and gated recurrent unit (MAPE = 2.974; RMSE = 3.230; Corr = 0.824) 
had similar performances. The linear regression models had the lowest performance (MAPE = 3.284; 
RMSE = 3.586; Corr = 0.770) compared with other models. Machine learning methods can accurately 
infer hemodialysis adequacy using continuously measured data from hemodialysis machines.
Dialysis adequacy is an important survival indicator in patients with chronic  hemodialysis1,2. Recent guidelines 
recommend that the dialysis dose should be adjusted using a blood test at least once per month and suggest a 
target single pool Kt/V (spKt/V) of 1.4 per hemodialysis session for patients treated thrice  weekly3. Although 
some hemodialysis devices estimate spKt/V using sodium clearance, it is limited to devices from specific manu-
factures and cannot be applied to all equipment. In contrast, the urea reduction ratio (URR) is easily calculated 
and used as a standard measurement for the delivered hemodialysis  dose4,5. However, there are disadvantages; 
it uses needles, exposes the medical staff and patients to blood, and has costs associated with processing and 
analyzing blood samples. Additionally, hemodialysis sessions are frequently terminated for reasons such as 
intradialytic hypotension, vascular access problems, and poor compliance. Therefore, URR is not easily measured 
regularly in practice.
During hemodialysis, several clinical parameters such as blood flow, ultrafiltration and dialysate flow rates, 
vessel pressure, temperature, and bicarbonate and sodium levels are continuously generated. Monitoring and 
recording these parameters in real-time is possible with the commercial software provided with the hemodialysis 
machine. Considering urea kinetics, some of these measurements, the type of dialyzer, and the dialysis duration 
may be related to dialysis adequacy. However, the relationship between these measurements and dialysis adequacy 
is not simple, and models using machine learning (ML) rather than traditional statistical models may be more 
appropriate for predicting dialysis adequacy. Artificial intelligence has already been used in the healthcare field 
for medical imaging, natural language processing, and  genomics6. Recently, studies also used ML or deep learn-
ing (DL) (a subfield of ML) to investigate kidney  disease7.
In this study, we hypothesized that the ML technique could predict dialysis adequacy in chronic hemodi-
alysis patients using clinical demographics and repeated measurements obtained during hemodialysis sessions. 
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This study aimed to build models that predict URR based on repeated measurement data from patients during 
hemodialysis.
Results
Hemodialysis sessions. This study included 1333 hemodialysis sessions corresponding to the monthly 
examination dates of 61 patients where URR was measured. The mean blood flow was 265.2 mL/min (SD, 41.4), 
the mean dialysate flow was 571.0 mL/min (SD, 116.3), the mean dialyzer surface area was 1.8  m2 (SD, 0.2), the 
mean URR was 77.7% (SD, 5.3), and the mean total ultrafiltration volume was 2209.0 mL (SD, 826.5) (Table 1). 
The fivefold cross-validation method divided the data into five approximately equal-sized portions (the mini-
mum and the maximum number of participants was 12 and 13, respectively). The total number of data points 
was 319,920.
Model performances. Table 2 summarizes the MAPE, RMSE, and Corr performance measurements for 
each model using the fivefold cross-validation. For the linear regression model, the models with time-fixed and 
time-varying covariates had better performances than the model with fixed covariates alone (MAPE = 3.546; 
RMSE = 3.785; Corr = 0.751). Among the time-varying covariates, the blood flow rate measurement improved 
performance the most (MAPE = 3.329; RMSE = 3.648; Corr = 0.766). The linear regression model with all covari-
ates had the best performance among the linear regression models (MAPE = 3.284; RMSE = 3.586; Corr = 0.770). 
However, the linear regression models had a lower performance than the ML and DL models. The ML methods 
had better performances than the other methods, and the XGBoost model had the best performance among 
the ML methods (MAPE = 2.500; RMSE = 2.906; Corr = 0.873). The DL models with the convolutional neural 
network (MAPE = 2.835; RMSE = 3.125; Corr = 0.833) and gated recurrent unit (MAPE = 2.974; RMSE = 3.230; 
Corr = 0.824) had similar performances. The detailed relationship between URR and the predicted values for 
each model are depicted using scatter plots in Fig. 1. The results of other hyperparemeter settings are summa-
rized in Supplementary Table S1.
Table 1.  Study subject characteristics (61 subjects, 1333 sessions). SD standard deviation, BUN blood urea 
nitrogen, HD hemodialysis, HDF hemodiafiltration, MSE mean square error.
Characteristics Mean or n SD or %
Female 704 53
Age, year 62.9 15.9
Pre-dialysis weight, kg 60.0 12.2
Height, cm 163.8 8.2
Dialyzer surface area,  m2 1.8 0.2
Pre-dialysis BUN, mg/dL 56.7 16.5
Total ultrafiltration volume, mL 2281.0 826.5
Type of hemodialysis
Conventional HD 670 50
HDF 663 50


















Urea reduction ratio (%) 77.7 5.3
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Feature importance. Feature importance was calculated for the random forest and XGBoost models to 
investigate which covariates affect the URR prediction the most (Fig. 2). Pre-dialysis weight was the most impor-
tant covariate for predicting URR in both models, followed by height and gender. Artificial features extracted by 
blood flow rate (i.e., the mean and intercept of the linear regression) had higher importance than other artificial 
features.
Sensitivity analyses. Sensitivity analyses were conducted to confirm the fivefold cross-validation results, 
which were performed in units of sessions instead of patients. After randomizing the sessions, the linear regres-
sion, ML, and DL models were trained, and the sensitivity analysis results were similar to the primary results 
(Table 3). The ML and DL models still performed better than the linear regression model. Sensitivity analysis was 
also performed on data that eliminated URR outliers to determine how outliers affected model fitting. Sessions 
Table 2.  A performance measurement summary for URR prediction models. URR urea reduction ratio, 
MAPE mean absolute percentage error, RMSE root mean square error, Corr Spearman’s rank correlation 
coefficient, BFR blood flow rate, XGBoost extreme gradient boosting, CNN convolutional neural network, 
GRU gated recurrent unit, BUN blood urea nitrogen level. a Time-fixed covariates: age, gender, dialyzer surface 
area, dialysis pre-weight, height, dialysis pre-BUN, and hemodialysis type (conventional hemodialysis or 
hemodiafiltration). Performance measures were calculated through fivefold cross-validation. b All covariates: 
time-fixed covariates, BFR, dialysate flow rate, and ultrafiltration volume.
Model Used covariates MAPE RMSE Corr
Linear regression
Time-fixed  covariatesa 3.546 3.785 0.751
Time-fixed  covariatesa + BFR 3.329 3.648 0.766
Time-fixed  covariatesa + flow 3.447 3.715 0.757
Time-fixed  covariatesa + volume 3.548 3.779 0.753
All variables 3.284 3.586 0.771
Random forest All  covariatesb 2.625 3.043 0.864
XGBoost All  covariatesb 2.500 2.906 0.873
Deep learning with CNN All  covariatesb 2.873 3.214 0.825
Deep learning with GRU All  covariatesb 2.857 3.237 0.828
Figure 1.  Scatter plots of URR and the predicted value for each model using Spearman’s rank correlation 
coefficient and the best fit line. (A) Linear regression (R = 0.771). (B) Random forest (R = 0.864). (C) XGBoost 
(R = 0.873). (D) Deep learning with convolutional neural network (R = 0.834). URR urea reduction ratio, 
XGBoost extreme gradient boosting.
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with URR values greater than the 95th percentile and less than the 5th percentile were removed. The model per-
formances are summarized in Table 3. The models had better performances after eliminating outliers. However, 
the performance differences among models were similar before and after outlier removal.
Figure 2.  Random forest and XGBoost feature importance plots. XGBoost extreme gradient boosting, MSE 
mean squared error, SD standard deviation, BFR blood flow rate, DFR dialysate flow rate, UV ultrafiltration 
volume.
Table 3.  Sensitivity analysis results for the cross-validation of units as hemodialysis sessions and outlier 
elimination. Models were trained through age, gender, dialyzer surface area, dialysis pre-weight, height, dialysis 
pre-BUN, hemodialysis type (conventional hemodialysis or hemodiafiltration), and the artificial features of 
BFR, dialysate flow rate, and ultrafiltration volume. CV cross-validation, MAPE mean absolute percentage 
error, RMSE root mean square error, Corr Spearman’s rank correlation coefficient, XGBoost extreme gradient 
boosting, CNN convolutional neural network, GRU gated recurrent unit, BUN blood urea nitrogen level.
Model
CV in unit of sessions Outlier elimination
MAPE RMSE Corr MAPE RMSE Corr
Linear regression 3.248 3.535 0.775 2.673 2.622 0.725
Random forest 2.526 2.944 0.876 2.018 1.996 0.854
XGBoost 2.444 2.854 0.881 1.993 1.968 0.852
Deep learning with CNN 2.891 3.145 0.830 2.220 2.191 0.817
Deep learning with GRU 2.963 3.241 0.826 2.239 2.225 0.811
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Discussion
Current guidelines recommend checking dialysis adequacy once per month because dialysis adequacy is related 
to the prognosis of end-stage kidney disease  patients3. However, determining adequacy is challenging owing to 
the cost and blood exposure. The prediction model used parameters that determine hemodialysis efficiency, such 
as blood flow and dialysate flow rates, dialysis time, and the dialyzer  type8–10. However, it is difficult to predict 
dialysis adequacy using these parameters through traditional statistical methods as the relationships between 
these parameters and urea clearance are not linear; they frequently change during hemodialysis with fluctuations 
in blood pressure or other symptoms. This study showed that ML and DL models using continuous measure-
ments obtained during hemodialysis predicted dialysis adequacy. Furthermore, there are significant implications 
in repeated measurements from hemodialysis machines for making such predictions. For example, there is no 
additional cost because the adequacy predictions are based on measurements obtained from any hemodialysis 
machine, making this approach useful when remote monitoring is required, such as with at-home hemodialysis.
DL has been mainly used for image processing, although recently, DL has also been used for predicting 
laboratory results or the short-term prognosis of patients based on continuously measured data. Additionally, 
large-scale intensive care unit datasets, such as the Medical Information Mart for Intensive Care  III11 and eICU 
Collaborative Research  Database12, and intra- or post-operative vital sign data are now available for use in 
 research13. Various studies have also used DL to investigate hemodialysis. Akl et al.14 suggested decades ago that 
the neural network can achieve artificial-intelligent dialysis control, and studies on intradialytic hypotension 
 predictions15–18, the optimal dry weight  setting19, and anemia  control20 for hemodialysis have been presented. 
DL in research has also expanded to other kidney diseases to predict acute kidney injury  outcomes21,22 and 
 hyperkalemia23. Despite challenges, such as data cleansing costs, the required modeling resources, and algorithm 
validations, the DL approach is expected to improve the prognosis of hemodialysis patients in the future.
There are some limitations to our study. First, despite a relatively large number of hemodialysis sessions, this 
study was conducted on a small number of patients. For this reason, DL models might show lower performances 
than random forest or XGBoost models in this study. A large, prospective study is needed to validate our model. 
Second, some factors influencing the blood urea nitrogen level during hemodialysis were not considered (e.g., 
the catabolic status, the exact residual renal function, and access recirculation). However, this study was based on 
outpatient clinic data with few acutely ill patients, and ultrafiltration (a factor affecting the blood urea nitrogen 
level) was included in our model. Therefore, the effect of the catabolic status was minimized. Finally, URR has 
been used as a standard method to measure the hemodialysis  dose4. However, the current guidelines do not 
recommend using URR for hemodialysis adequacy. Nevertheless, URR is widely used in clinics because it is easy 
to calculate and has a similar sensitivity to urea reduction compared with other  methods24. Models that predict 
spKt/V require verification in the future.
In conclusion, ML can accurately infer hemodialysis adequacy through repeatedly measured data during 
hemodialysis sessions. We expect to be able to develop personalized hemodialysis profile recommendation 
models through prospective data collection soon.
Materials and methods
Study population. The data were extracted from the Severance Hospital hemodialysis database, which 
stores information about each hemodialysis session. A total 21,004 sessions of 75 outpatients aged over 19 which 
were automatically recorded in the Therapy Data Management System from May 2015 to September 2020 were 
screened. Among them, 61 patients who were examined for dialysis adequacy regularly were finally selected and 
clinical information including dialysis adequacy was additionally collected. The study was performed following 
the Declaration of Helsinki principles, and the Severance Hospital institutional review board approved this study 
(no. 4-2021-0056) and waived informed consent as only de-identified, previously collected data was accessed.
Data collection and measurements. Demographic and anthropometric data (including sex and age) 
were collected corresponding to the hemodialysis date from electric medical records. Blood pressure, the vas-
cular access type (arteriovenous fistula, arteriovenous graft, and catheter), and the dialyzer type (surface area) 
were recorded at the initiation of each hemodialysis session. Data, including blood flow and ultrafiltration rates, 
bicarbonate and sodium levels, dialysate flow, vein and artery pressures, and the dialysate temperature, were 
measured every minute from the start of each session unless problems or interventions occurred. Monitoring 
software linked to each dialysis machine recorded the hemodialysis measurements in real-time and collected 
240 measurements (about 4 h) from each session; missing values were completed using an interpolation method. 
URR (the blood urea concentration decrease [%] during hemodialysis) was measured as an indicator of dialysis 
adequacy. All hemodialysis sessions included in this study used the Fresenius 5008S (Fresenius Medical Care, 
Bad Homburg, Germany) hemodialysis device.
Model building. Linear regression was considered the base model for performance comparisons with ML 
and DL algorithms. Random  forest25 and  XGBoost26 were chosen for the ML algorithms. The convolutional neu-
ral network and gated recurrent  unit27 architectures were chosen for the DL algorithms to extract features from 
time-varying covariates. The DL algorithms were trained with a batch size of 128, Adam  optimizer28 and the 
root mean squared error (RMSE) loss function. The detailed architectures of the DL algorithms are illustrated in 
Supplementary Figure S1 and Supplementary Figure S2. The hyperparameters were optimized to minimize the 
RMSE through a random search with fivefold cross-validation in ML algorithms. All selected hyperparameters 
are described in Supplementary Table S1.
Covariates were normalized to have values between 0 and 1 in the DL algorithms, which can automatically 
extract features from time-varying covariates. In contrast, the linear regression and ML algorithms require a 
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data pre-processing step to extract artificial features from time-varying covariates. Thus, the means and stand-
ard deviations (SDs) from time-varying covariates by session for the linear regression and ML algorithms were 
extracted, and then, a linear regression for the time-varying covariates by session was implemented. From this 
linear regression, the intercept, coefficient, and mean squared error (MSE) were extracted.
Statistical analyses. Descriptive statistics were used to describe covariates. Categorical variables were 
expressed as the number of patients and percentages, and continuous variables were presented as the mean and 
SD. The mean absolute percentage error (MAPE), RMSE, and Spearman’s rank correlation coefficient (Corr) 
were calculated for performance evaluation using fivefold cross-validation. Two sensitivity analyses were also 
performed for result confirmation. First, each session was regarded as belonging to a different person. Then, 
the main analysis was repeated after eliminating URR outliers. Analyses, including the linear regression and 
ML algorithms, were performed using R software (version 3.6.1; www.r- proje ct. org; R Foundation for Statisti-
cal Computing, Vienna) with the authors’ own program written code using the XGBoost and ranger packages. 
Python software (version 3.7; www. python. org; Python Software Foundation, Wilmington) was used with the 
Keras library for the DL algorithms. A computer with a Xeon processor (24 core, Intel, USA) and Quadro RTX 
6000 (Nvidia, USA) was used for all analyses.
Data availability
The datasets generated during the current study are not publicly available due to the data security requirement 
of our hospital.
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